Elicio Therapeutics Inc (ELTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 34,607 | 5,571 | N/A | N/A |
| Receivables | N/A | 440 | N/A | N/A |
| TOTAL | $42,297 | $6,106 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 156 | 209 | N/A | N/A |
| Investments And Advances | 822 | 999 | 0 | 0 |
| Other Non-Current Assets | 4,072 | 4,572 | 0 | 0 |
| TOTAL | $5,050 | $5,780 | $N/A | $N/A |
| Total Assets | $47,347 | $11,886 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 260 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 5,578 | 11,239 | 0 | 0 |
| Accrued Expenses | 6,665 | 2,661 | N/A | N/A |
| Other current liabilities | 39,223 | 5,794 | N/A | N/A |
| TOTAL | $107,449 | $26,575 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 635 | N/A | N/A | N/A |
| Deferred Revenues | 3,942 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 3,847 | 3,897 | 0 | 0 |
| TOTAL | $30,347 | $3,897 | $N/A | $N/A |
| Total Liabilities | $137,796 | $30,472 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 156 | 148 | N/A | N/A |
| Retained earnings | -160,562 | -80,455 | N/A | N/A |
| Other shareholders' equity | -179 | 190 | 0 | 0 |
| TOTAL | $-90,449 | $-18,586 | $N/A | $N/A |
| Total Liabilities And Equity | $47,347 | $11,886 | $0 | $0 |